Ian Ford

68.3k total citations · 19 hit papers
357 papers, 34.1k citations indexed

About

Ian Ford is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ian Ford has authored 357 papers receiving a total of 34.1k indexed citations (citations by other indexed papers that have themselves been cited), including 160 papers in Cardiology and Cardiovascular Medicine, 104 papers in Surgery and 55 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ian Ford's work include Lipoproteins and Cardiovascular Health (61 papers), Cardiac Imaging and Diagnostics (47 papers) and Blood Pressure and Hypertension Studies (37 papers). Ian Ford is often cited by papers focused on Lipoproteins and Cardiovascular Health (61 papers), Cardiac Imaging and Diagnostics (47 papers) and Blood Pressure and Hypertension Studies (37 papers). Ian Ford collaborates with scholars based in United Kingdom, Netherlands and United States. Ian Ford's co-authors include James Shepherd, Stuart M. Cobbe, Peter W. Macfarlane, Christopher J. Packard, A R Lorimer, Christopher Isles, James H. McKillop, Chris J. Packard, Naveed Sattar and Allan Gaw and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Ian Ford

345 papers receiving 32.7k citations

Hit Papers

Prevention of Coronary He... 1989 2026 2001 2013 1995 2002 2003 1989 1998 1000 2.0k 3.0k 4.0k 5.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
    1995 5.8k citations Stuart M. Cobbe, Ian Ford et al. profile →
  2. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
    2002 2.4k citations Brendan M. Buckley, Stuart M. Cobbe et al. profile →
  3. Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study
    2003 1.2k citations Naveed Sattar, Ian Ford et al. Circulation profile →
  4. Diffuse axonal injury in head injury: Definition, diagnosis and grading
    1989 836 citations Ian Ford et al. profile →
  5. Biochemical detection of left-ventricular systolic dysfunction
    1998 781 citations Ian Ford, John J.V. McMurray et al. profile →
  6. Nonparametric Analysis of Statistic Images from Functional Mapping Experiments
    1996 751 citations Ian Ford et al. profile →
  7. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
    2015 735 citations Ian Ford et al. profile →
  8. Lipoprotein-Associated Phospholipase A2as an Independent Predictor of Coronary Heart Disease
    2000 671 citations Chris J. Packard, Ian Ford et al. profile →
  9. Pravastatin and the Development of Diabetes Mellitus
    2001 667 citations John Norrie, Naveed Sattar et al. Circulation profile →
  10. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial
    2004 612 citations Ian Ford, Naveed Sattar et al. profile →
  11. C-Reactive Protein Is an Independent Predictor of Risk for the Development of Diabetes in the West of Scotland Coronary Prevention Study
    2002 597 citations John Norrie, Ian Ford et al. profile →
  12. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study
    2007 572 citations Ian Ford, Chris J. Packard et al. profile →
  13. Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex
    2013 520 citations Kenneth Dickstein, Ian Ford et al. profile →
  14. Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry
    2012 505 citations Philippe Gabríel Steg, Nicola Greenlaw et al. European Heart Journal profile →
  15. Electronic health records to facilitate clinical research
    2016 396 citations Martín Cowie, Ian Ford et al. profile →
  16. Ischaemic brain damage is still common in fatal non-missile head injury.
    1989 386 citations Ian Ford et al. profile →
  17. Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting
    2017 349 citations Ian Ford, Naveed Sattar et al. Circulation profile →
  18. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study
    2016 298 citations Ian Ford, Nicola Greenlaw et al. profile →
  19. Intravenous Iron in Patients Undergoing Maintenance Hemodialysis
    2018 293 citations Iain C. Macdougall, Stefan D. Anker et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ian Ford 12.0k 11.6k 6.8k 5.3k 3.5k 357 34.1k
Patrick E. McBride 12.5k 1.0× 10.5k 0.9× 7.8k 1.2× 3.4k 0.6× 3.7k 1.1× 119 29.9k
Michael Pencina 12.9k 1.1× 9.4k 0.8× 7.2k 1.1× 4.9k 0.9× 2.9k 0.8× 330 36.2k
Richard C. Pasternak 10.0k 0.8× 11.5k 1.0× 9.4k 1.4× 3.6k 0.7× 3.4k 1.0× 93 28.3k
Curt D. Furberg 17.5k 1.5× 8.8k 0.8× 8.9k 1.3× 3.6k 0.7× 3.7k 1.1× 340 39.0k
Salim S. Virani 11.0k 0.9× 8.3k 0.7× 4.8k 0.7× 2.8k 0.5× 3.1k 0.9× 734 25.2k
Nancy R. Cook 14.3k 1.2× 8.8k 0.8× 6.8k 1.0× 8.3k 1.6× 2.2k 0.6× 440 51.2k
Kalevi Pyörälà 12.8k 1.1× 12.7k 1.1× 15.1k 2.2× 4.6k 0.9× 3.6k 1.0× 231 34.4k
Robert H. Eckel 8.6k 0.7× 9.5k 0.8× 7.1k 1.1× 3.5k 0.7× 2.9k 0.8× 168 28.4k
Bruce M. Psaty 20.6k 1.7× 6.6k 0.6× 7.0k 1.0× 6.4k 1.2× 2.6k 0.7× 642 46.3k
Neil J. Stone 15.3k 1.3× 18.9k 1.6× 14.3k 2.1× 5.6k 1.1× 6.3k 1.8× 191 45.2k

Countries citing papers authored by Ian Ford

Since Specialization
Citations

This map shows the geographic impact of Ian Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Ford more than expected).

Fields of papers citing papers by Ian Ford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Ford. The network helps show where Ian Ford may publish in the future.

Co-authorship network of co-authors of Ian Ford

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Ford. A scholar is included among the top collaborators of Ian Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Ford. Ian Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Picard, Fabien, Grégory Ducrocq, Yedid Elbez, et al.. (2023). New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registry. European Heart Journal. 45(5). 366–375. 8 indexed citations
2.
Kalra, Paul R., John G.F. Cleland, Mark C. Petrie, et al.. (2022). Rationale and design of a randomised trial of intravenous iron in patients with heart failure. Heart. 108(24). 1979–1985. 6 indexed citations
3.
Greenlaw, Nicola, James G. Boyle, Nish Chaturvedi, et al.. (2021). Metformin and carotid intima‐media thickness in never‐smokers with type 1 diabetes: The REMOVAL trial. Diabetes Obesity and Metabolism. 23(6). 1371–1378. 14 indexed citations
4.
Markus, Hugh S., Susanna C. Larsson, John Dennis, et al.. (2019). Vertebral artery stenting to prevent recurrent stroke in symptomatic vertebral artery stenosis: the VIST RCT. Health Technology Assessment. 23(41). 1–30. 16 indexed citations
5.
Bivard, Andrew, Xuya Huang, Christopher Levi, et al.. (2019). Comparing mismatch strategies for patients being considered for ischemic stroke tenecteplase trials. International Journal of Stroke. 15(5). 507–515. 4 indexed citations
6.
Delles, Christian, Naomi Rankin, Charles Boachie, et al.. (2018). Nuclear magnetic resonance‐based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation:results from PROSPER and FINRISK 1997. University of Oulu Repository (University of Oulu). 51 indexed citations
7.
Vallejo‐Vaz, Antonio J., Michele Robertson, Alberico L. Catapano, et al.. (2017). Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above. Circulation. 136(20). 1878–1891. 118 indexed citations
8.
Ford, Ian, Heather Murray, Colin McCowan, & Chris J. Packard. (2016). Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin Therapy. Circulation. 133(11). 1073–1080. 169 indexed citations
9.
Meredith, Peter, Suzanne M. Lloyd, Ian Ford, & Henry L. Elliott. (2016). Importance of sustained and “tight” blood pressure control in patients with high cardiovascular risk. Blood Pressure. 25(2). 74–82. 10 indexed citations
10.
Chaturvedi, Nish, Ian Ford, Irene Hramiak, et al.. (2016). Metformin in type 1 diabetes: methods and baseline characteristics of the REMOVAL trial. UCL Discovery (University College London). 1 indexed citations
11.
Colhoun, Helen M., et al.. (2016). The REMOVAL trial (Reducing with Metformin Vascular Adverse Lesions) in Type 1 diabetes: methods and baseline characteristics. UCL Discovery (University College London). 1 indexed citations
12.
Ponikowski, Piotr, Gerasimos Filippatos, Josep Comín Colet, et al.. (2015). The Impact of Intravenous Ferric Carboxymaltose on Renal Function: An Analysis of the FAIR-HF Study. European Journal of Heart Failure. 17(3). 329–339. 82 indexed citations
13.
Filippatos, Gerasimos, Dimitrios Farmakis, Josep Comín Colet, et al.. (2013). Intravenous Ferric Carboxymaltose in Iron-Deficient Chronic Heart Failure Patients with and Without Anaemia: a Subanalysis of the FAIR-HF Trial. European Journal of Heart Failure. 15(11). 1267–1276. 111 indexed citations
14.
Jackson, Colette E., Rachel C. Myles, Jonathan R. Dalzell, et al.. (2013). Spectral Microvolt T-Wave Alternans Testing has no Prognostic Value in Patients Recently Hospitalized with Decompensated Heart Failure. European Journal of Heart Failure. 15(11). 1253–1261. 7 indexed citations
15.
Nanchen, David, David J. Stott, Jacobijn Gussekloo, et al.. (2012). Resting Heart Rate and Incident Heart Failure and Cardiovascular Mortality in Older Adults: Role of Inflammation and Endothelial Dysfunction: The PROSPER Study. European Journal of Heart Failure. 15(5). 581–588. 56 indexed citations
16.
Jackson, Colette E., Rachel C. Myles, Jonathan R. Dalzell, et al.. (2012). Profile of Microvolt T-Wave Alternans Testing in 1003 Patients Hospitalized with Heart Failure. European Journal of Heart Failure. 14(4). 377–386. 17 indexed citations
17.
Veldhuisen, Dirk J. van, Frieder Braunschweig, Viviane M. Conraads, et al.. (2011). Intrathoracic Impedance Monitoring, Audible Patient Alerts, and Outcome in Patients With Heart Failure. Circulation. 124(16). 1719–1726. 310 indexed citations
18.
Jackson, Colette E., Jonathan R. Dalzell, Vladimir Bezlyak, et al.. (2009). Red Cell Distribution width has Incremental Prognostic Value to B-Type Natriuretic Peptide in Acute Heart Failure. European Journal of Heart Failure. 11(12). 1152–1154. 50 indexed citations
19.
Braunschweig, Frieder, Ian Ford, Viviane M. Conraads, et al.. (2008). Can Monitoring of Intrathoracic Impedance Reduce Morbidity and Mortality in Patients with Chronic Heart Failure? Rationale and Design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF). European Journal of Heart Failure. 10(9). 907–916. 42 indexed citations
20.
Norrie, John, et al.. (2005). Statin prescribing: is the reality meeting the expectations of primary care?. ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick E. McBride Breakdown of academic impact, for papers by Michael Pencina Breakdown of academic impact, for papers by Richard C. Pasternak Breakdown of academic impact, for papers by Curt D. Furberg Breakdown of academic impact, for papers by Salim S. Virani Breakdown of academic impact, for papers by Nancy R. Cook Breakdown of academic impact, for papers by Kalevi Pyörälà Breakdown of academic impact, for papers by Robert H. Eckel Breakdown of academic impact, for papers by Bruce M. Psaty Breakdown of academic impact, for papers by Neil J. Stone
Rankless by CCL
2026